| MOPEC12 | HIV risk among men who have sex with both men and women in Australia: findings from national behavioural surveillance surveys | Poster exhibition | Modelling the HIV epidemic |
| EPA0083 | Engineering macaque B cells for persistent anti-HIV broadly neutralizing antibodies production | E-poster | Novel treatment and prevention strategies |
| EPA0084 | (5R)-5-Hydroxytriptolide inhibits immune activation in SIV-infected ART-treated rhesus macaques | E-poster | Novel treatment and prevention strategies |
| EPA0085 | Dual therapy of Interleukin-21 and anti-α4β7 antibody administration during ART-treated SIV promotes immunological responses and ameliorates dysbiosis in rhesus macaques | E-poster | Novel treatment and prevention strategies |
| EPA0086 | Claisened Hexafluoro treatment ameliorates cognitive deficits in HIV associated neurocognitive disorders (HAND) mice and improves the underlying brain pathogenicity | E-poster | Novel treatment and prevention strategies |
| LBPEA01 | Broad HIV-1 inhibition elicited by human data-driven HIVconsvX conserved T-cell vaccines vectored by ChAdOx1 and MVA in HIV-CORE 005.2: an open-label, non-randomized, dose-escalation, first-in-man phase 1 trial | Poster exhibition | Novel treatment and prevention strategies |
| OAA0203 | In vivo genome engineering of human T cells results in ART-free control of HIV-1 in humanized mice | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OAA0204 | The EZH2 inhibitor Tazemetostat increases MHC-I antigen presentation in vitro and in vivo, enhancing antiviral activities of HIV-specific CTLs | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OAA0205 | Anti-PD-1 chimeric antigen receptor T cells efficiently target SIV-infected CD4+ T cells in germinal centers of rhesus macaques | Oral abstract session with live Q&A | Novel treatment and prevention strategies |
| OALBA0504 | Absence of viral rebound for 18 months without antiretrovirals after allogeneic hematopoietic stem cell transplantation with wild-type CCR5 donor cells to treat a biphenotypic sarcoma | Oral abstract session with live Q&A | Novel treatment and prevention strategies |